Combating Controlled Substance Abuse: Link between CS Score and Health Outcomes


	Click here to view this message in a web browser

	During the past decade, drug overdose deaths have more than doubled and over 50 percent were related to prescription drugs. Increases in controlled substance prescribing have coincided with higher rates of misuse, abuse, hospitalizations and deaths. Right now, opioids cause more overdose deaths than heroin and cocaine combined. To address this growing epidemic, Prime Therapeutics LLC has developed a controlled substance (CS) score that identifies high risk CS drug use. Through analysis of the CS score, Prime found a significant association between CS scores and health outcomes (hospitalizations and emergency room visits), CS drug costs, and total cost of care. The CS score can help health plans identify and intervene with high risk members, and validating the CS score association with health care use and costs helps quantify the potential value of an intervention. Please join the Prime Therapeutics's Cathy Starner on Thursday, May 21st, 2015 at 1PM Eastern as she reviews the scope of the controlled substance abuse epidemic and a variety of methods to detect misuse and abuse, and then discusses the Prime CS Score study, its implications, and opportunities for stakeholders to lightly manage or aggressively manage the problem; during the Healthcare Web Summit event: Combatting Controlled Substance Abuse. Click here for detailed information and to register or call 209.577.4888.